Younong Xu

1 ta ish

Etubics (United States)

1. A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses

   Elizabeth S. Gabitzsch, Younong Xu, Lois H. Yoshida +4

   Maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.717208